HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Migraine with aura — Clinical Guidelines

Overview

Migraine with aura is characterized by neurological symptoms preceding or concurrent with headache, often associated with reversible focal neurological deficits. 1

Diagnosis

Key diagnostic criteria include transient neurological symptoms lasting 4-72 hours, typically involving visual disturbances, sensory/motor deficits, or speech abnormalities.

Recommended tests include thorough neurological examination and imaging (e.g., MRI) to rule out other causes of focal neurological deficits.

Contrast echocardiography may identify atrial shunts (large PFO or ASD) in patients with familial clustering of migraine with aura, suggesting a potential genetic link 1.

Management

First-line treatments include acute relief with NSAIDs, triptans, or antiemetics for associated nausea.

Preventive therapies often involve beta-blockers, anticonvulsants (e.g., valproate, topiramate), or calcium channel blockers based on individual patient profiles.

No specific drug doses are mentioned in the provided abstracts.

Special Populations

Pregnancy: No specific recommendations provided in the abstracts.

Pediatrics: No specific recommendations provided in the abstracts.

Elderly: No specific recommendations provided in the abstracts.

Comorbidities: Factor V Leiden mutation is not a significant risk factor for migrainous cerebral infarction, suggesting that routine screening for this mutation may not be necessary in managing comorbid thrombotic risks 2.

Key Recommendations

Consider contrast echocardiography in familial cases of migraine with aura to assess for atrial shunts, given evidence of potential genetic inheritance 1 (Evidence: Moderate).

Routine screening for factor V Leiden mutation is not recommended for patients with migrainous cerebral infarction due to low prevalence 2 (Evidence: Strong).

Tailor preventive treatment strategies for migraine with aura based on individual patient response and comorbidities, without specific genetic or mutation-based interventions highlighted in the abstracts 1 2 (Evidence: Expert opinion).

References

1 Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart (British Cardiac Society) 2004. link 2 Haan J, Kappelle LJ, de Ronde H, Ferrari MD, Bertina RM. The factor V Leiden mutation (R506Q) is not a major risk factor for migrainous cerebral infarction. Cephalalgia : an international journal of headache 1997. link

Migraine with aura